Sight Restored: Gene Therapy Breakthrough Wins Major Science Prize
TL;DR Summary
A married couple and investigator Katherine High share a $3 million Breakthrough Prize for Luxturna, the gene therapy approved in 2017 that restores vision in people with Leber congenital amaurosis by delivering a working RPE65 gene to retinal cells; the 25-year project produced dramatic patient improvements and was celebrated at a Los Angeles ceremony, while scientists warned about politicized attacks on science and other prize-winning work highlighted advances in gene therapies for blood disorders.
- ‘Oscar of science’ awarded to team behind gene therapy that restores lost vision The Guardian
- Four Boston-area researchers honored with 2026 Breakthrough Prize, the ‘Oscars of Science’ The Boston Globe
- BNL scientist wins prestigious Breakthrough Prize in Physics Newsday
- Philly scientists win 2026 Breakthrough Prize for developing gene therapy for blindness Inquirer.com
- $3 million prize goes to duo whose research led to first sickle cell CRISPR therapy Live Science
Reading Insights
Total Reads
0
Unique Readers
6
Time Saved
3 min
vs 4 min read
Condensed
90%
773 → 74 words
Want the full story? Read the original article
Read on The Guardian